Baculi, Gemmalyn B.
HRN: 24-48-96 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/09/2024
CEFTRIAXONE 1G (VIAL)
02/09/2024
02/16/2024
IV
2 Grams
Once Daily
T/C TBI Mild, Multiple Soft Tissue Injury Secondary To MVA (2 Wheel, Non Collision)
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes